Abstract
Gene replacement or gene reactivation therapies for sickle-cell disease (SCD) typically target the mutant βS-globin subunits of hemoglobin-S (α2βS2) for substitution by nonpathological β-like globins. Here we show, in vitro and in vivo in a transgenic mouse model of SCD, that the adverse properties of hemoglobin-S can be reversed by exchanging its normal α-globin subunits for ζ-globin, an endogenous, developmentally silenced, non-β-like globin.
Similar content being viewed by others
References
Bunn, H.F. & Forget, B.G. in Hemoglobin: Molecular, Genetic, and Clinical Aspects 502–564 (W.B. Saunders, Philadelphia, 1986).
Pastzy, C. et al. Science 278, 876–879 (1997).
Liebhaber, S.A. et al. Mol. Cell. Biol. 16, 2637–2646 (1996).
Chang, J. et al. Blood 88, 1846–1851 (1996).
He, Z. & Russell, J.E. Anal. Biochem. 349–352 (2002).
Edelstein, S.J. J. Mol. Biol. 150, 557–575 (1981).
Huang, B.L. et al. Proc. Natl. Acad. Sci. USA 95, 14669–14674 (1998).
Liu, J.-J., Hou, S.-C. & Shen, C.-K.J. J. Biol. Chem. 278, 19534–19540 (2003).
Wang, Z. & Liebhaber, S.A. EMBO J. 18, 2218–2228 (1999).
Chui, D.H.K. et al. N. Engl. J. Med. 314, 76–79 (1986).
Tang, W. et al. Blood 81, 1636–1640 (1993).
Papayannopoulou, T. et al. Blood 77, 2569–2576 (1991).
Acknowledgements
This research was supported by National Institutes of Health grants HL61399 and HL67118.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
He, Z., Russell, J. Antisickling effects of an endogenous human α-like globin. Nat Med 10, 365–367 (2004). https://doi.org/10.1038/nm1022
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1022
- Springer Nature America, Inc.
This article is cited by
-
Unannotated single nucleotide polymorphisms in the TATA box of erythropoiesis genes show in vitro positive involvements in cognitive and mental disorders
BMC Medical Genetics (2020)
-
Structural determinants of human ζ-globin mRNA stability
Journal of Hematology & Oncology (2014)